NUclear MEdicine DIagnostic and Artificial Intelligence
NUMEDIA
Contribution to Disease Diagnosis and Prognosis Based on the Fusion of Expert Knowledge, Nuclear Medicine Imaging and Artificial Intelligence (AI) Tools
1 other identifier
observational
1
1 country
1
Brief Summary
Artificial intelligence algorithms for parathyroid adenoma detection in parathyroid scans The aim of the study is to develop programs for the automatic subtraction of planar and tomographic parathyroid images and for the localization of parathyroid adenomas using artificial intelligence tools. Inclusion criteria Patients having undergone a double isotope parathyroid diagnostic examination using the standard Besançon University Hospital protocol (double injection of 123I and 99mTc, pinhole image, low energy high resolution (LEHR) and (single-photon emission tomography / Computed tomography) SPECT/CT +/- (positron emission tomography (PET) Choline). Secondary endpoints Concordance between diagnoses made by nuclear physicians using both methods (current method and new treatment method).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2023
CompletedFirst Posted
Study publicly available on registry
July 27, 2023
CompletedStudy Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
February 7, 2024
July 1, 2023
3 years
July 13, 2023
February 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Development of an artificial intelligence diagnostic program
Development of an artificial intelligence diagnostic program
through study completion, an average of 4 years
Secondary Outcomes (1)
Development of an automatic program for subtracting double-isotope parathyroid images.
through study completion, an average of 2 years
Interventions
the study aims to set up an artificial intelligence diagnostic assistance program
Eligibility Criteria
Men and women over 18 years of age who have undergone dual-isotope parathyroid scintigraphy (standard acquisition protocol (123I injection followed by 99mTc 3 hours after LEHR, PINHOLE and SPECT/CT acquisitions).
You may qualify if:
- Men and women over 18 years of age who underwent dual-isotope parathyroid scintigraphy.
- No refusal to use data for research purposes
- Retrospective data (after 13/04/2022: Date of posting of patient information in the department) and prospective data
You may not qualify if:
- Patient refusal to use data for research purposes
- Patients who did not benefit from the standard acquisition protocol (123I injection followed by 99mTc 3 hours after LEHR, PINHOLE and SPECT/CT acquisitions)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Besancon
Besançon, 25030, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 13, 2023
First Posted
July 27, 2023
Study Start
August 1, 2023
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
August 1, 2027
Last Updated
February 7, 2024
Record last verified: 2023-07